Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Puri T
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 1 到 5 筆資料,總共 5 筆
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2016
First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results from a Randomized Phase III Trial
Boye M; Wang X; Srimuninnimit V; Kang J.H; Tsai C.-M; Orlando M; Puri T; Kim J.S; Rajan N; CHIH-HSIN YANG
Clinical Lung Cancer
12
13
2016
Gefitinib maintenance therapy versus gefitinib monotherapy in east asian never-smoker patients with locally advanced or metastatic nonsquamous non-small cell lung cancer: Final overall survival results from a randomized phase 3 study
CHIH-HSIN YANG
; Srimuninnimit V; Ahn M.-J; CHIA-CHI LIN
; Kim S.-W; Tsai C.-M; Mok T; Orlando M; Puri T; Wang X; Park K.
Journal of Thoracic Oncology
22
20
2016
Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations
Cheng Y.; Murakami H; PAN-CHYR YANG
; He J; Nakagawa K; Kang J.H; Kim J.-H; Wang X; Enatsu S; Puri T; Orlando M; CHIH-HSIN YANG
Journal of Clinical Oncology
160
134
2017
Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al
CHIH-HSIN YANG
; Puri T; Orlando M; Cheng Y.
Journal of Clinical Oncology
0
0
2018
A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non–Small-Cell Lung Cancer
CHIH-HSIN YANG
; Mok T; Han B; Orlando M; Puri T; Park K.
Clinical Lung Cancer
18
17